Clin2
NCT06611592Possibly a fitRecruiting

Pramipexole for hard-to-treat OCD

Obsessive-Compulsive Disorder

Treatments studied

Part of Mental health clinical trials.

This study tests if pramipexole can help people whose OCD hasn't improved with standard treatments like SSRIs or certain antipsychotics. You might qualify if standard therapies haven't worked for you.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 2
Enrollment
48 people
Ages
18 years to 64 years
Study type
Interventional

Who can take part

  • You are between 18 and 64 years old
  • Your native language is European Portuguese
  • You have been diagnosed with obsessive-compulsive disorder (OCD)
  • You have tried at least two different SSRIs (antidepressants) at a high enough dose for 12 weeks and they did not help enough
  • You have also tried risperidone or aripiprazole with an SSRI for 12 weeks and still have moderate to severe OCD symptoms

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07111988Not yet recruiting· Phase 2
Valbenazine for obsessive-compulsive disorder

This study tests whether a medication called valbenazine can help reduce symptoms of moderate to severe OCD in adults. If you have OCD and are not currently changing your treatment, you may be able to join and see if this new approach works for you.

NCT06017713Recruiting
Brain stimulation plus exposure for stubborn OCD

This trial tests whether a gentle brain stimulation (tDCS) combined with facing your fears can help people with hard-to-treat OCD. If you've tried multiple treatments without relief, this study may offer a new option.

Poitiers
NCT07429500Not yet recruiting
Brain stimulation for hard-to-treat OCD

This trial tests if a gentle brain stimulation technique called tDCS can help people with severe, long-lasting obsessive-compulsive disorder that hasn't improved with other treatments. It aims to see if symptoms can be triggered and then reduced.

Angoulême
NCT04539951Recruiting· Phase 2
Trial for newly treated obsessive-compulsive disorder

This phase 2 study tests an OCD treatment strategy for people who have not yet had OCD medications or recent OCD therapy. It aims to reduce OCD symptoms, especially for those with moderate-to-severe symptom levels.

Shanghai, Shanghai Municipality
NCT06992999Not yet recruiting· Phase 1/Phase 2
Psilocybin for treating OCD

This study tests if a single dose of psilocybin, a psychedelic substance, can safely help people with obsessive-compulsive disorder (OCD) who have not responded well to standard treatments. If you have moderate to severe OCD and have tried at least one recommended treatment without success, you may be able to join.

Tucson, Arizona
NCT07303946Not yet recruiting
Deep brain stimulation for hard-to-treat OCD

This trial tests a treatment called deep brain stimulation (DBS) for OCD that hasn't improved with standard treatments. Small electrodes are placed in specific brain areas to see if they can reduce severe OCD symptoms.

Hear when a new Obsessive-Compulsive Disorder trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.